Atricure Inc. buy Needham & Company LLC
Start price
10.04.24
/
50%
€29.32
Target price
10.04.25
€42.66
Performance (%)
-
End price
11.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -5.701% | -5.701% | -52.242% |
| iShares Core DAX® | 1.631% | -0.020% | 22.800% |
| iShares Nasdaq 100 | 1.073% | 5.074% | 17.146% |
| iShares Nikkei 225® | -0.615% | 5.550% | 8.426% |
| iShares S&P 500 | 1.061% | 3.163% | 11.165% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten